Fund shareholders of ABCELLERA BIOLOGICS INC
ISIN CA00288U1066 · Canada · LEI 9845000861BC95FF9F73
- Fund shareholders
- 29
- Of which ETFs
- 11 18 other funds
- Value held
- ≈ 155.2M $ 154.3M $ · 452.4K € · 3.8M SEK
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| SMALLCAP World Fund Inc SMALLCAP World Fund Inc | 13,228,596 | 103.8M $ | 0.11 % | as of Jun 30, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 1,656,204 | 13M $ | 0.14 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC. | 1,053,900 | 8.3M $ | 0.06 % | as of Jun 30, 2026 ↗ |
| Counterpoint Quantitative Equity ETF NORTHERN LIGHTS FUND TRUST III | 971,643 | 7.6M $ | 2.07 % | as of Jun 30, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio Developed World ex-US ETF SPDR INDEX SHARES FUNDS | 564,320 | 4.4M $ | 0.01 % | as of Jun 30, 2026 ↗ |
| iShares Genomics Immunology and Healthcare ETF iShares Trust | 508,935 | 2.9M $ | 1.52 % | as of Jul 31, 2026 ↗ |
| SMALLCAP World Fund AMERICAN FUNDS INSURANCE SERIES | 359,753 | 2.8M $ | 0.11 % | as of Jun 30, 2026 ↗ |
| BlackRock Advantage Small Cap Core Fund BlackRock Funds | 339,622 | 2.1M $ | 0.04 % | as of May 29, 2026 ↗ |
| Driehaus Micro Cap Growth Fund Driehaus Mutual Funds | 246,560 | 1.9M $ | 0.32 % | as of Jun 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 180,133 | 1.1M $ | 0.00 % | as of May 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) International Small Cap ETF SPDR INDEX SHARES FUNDS | 166,042 | 1.3M $ | 0.15 % | as of Jun 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index ETF Fidelity Commonwealth Trust | 134,674 | 830.9K $ | 0.01 % | as of May 31, 2026 ↗ |
| Small Cap Value Fund Northern Funds | 123,712 | 971.1K $ | 0.14 % | as of Jun 30, 2026 ↗ |
| Adara Smaller Companies Fund RBB Fund, Inc. | 120,162 | 741.4K $ | 0.09 % | as of May 31, 2026 ↗ |
| Handelsbanken Global Småbolag Index Criteria Handelsbanken Fonder AB | 115,700 | 3.8M SEK | 0.01 % | as of Mar 31, 2026 ↗ |
| Avantis U.S. Equity ETF American Century ETF Trust | 64,811 | 399.9K $ | 0.00 % | as of May 31, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 59,315 | 338.7K $ | 0.73 % | as of Jul 31, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 57,800 | 453.7K $ | 0.01 % | as of Jun 30, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 40,673 | 251K $ | 0.03 % | as of May 31, 2026 ↗ |
| Avantis U.S. Small Cap Equity ETF American Century ETF Trust | 39,804 | 245.6K $ | 0.01 % | as of May 31, 2026 ↗ |
| Invesco RAFI Developed Markets ex-U.S. Small-Mid ETF Invesco Exchange-Traded Fund Trust II | 34,272 | 195.7K $ | 0.06 % | as of Jul 31, 2026 ↗ |
| Small Cap Core Fund Northern Funds | 28,561 | 224.2K $ | 0.06 % | as of Jun 30, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 16,253 | 100.3K $ | 0.15 % | as of May 31, 2026 ↗ |
| Diversified Equity Alpha Master Portfolio Master Investment Portfolio | 13,458 | 105.6K $ | 0.00 % | as of Jun 30, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 11,209 | 69.2K $ | 0.09 % | as of May 31, 2026 ↗ |
| Avantis U.S. Equity Fund American Century ETF Trust | 4,396 | 27.1K $ | 0.00 % | as of May 31, 2026 ↗ |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 261.9K € | 0.32 % | as of Dec 31, 2025 ↗ | |
| GESTION BOUTIQUE VIII, FI GESTION BOUTIQUE VIII / INVER VALUE GLOBAL FUND ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 109.2K € | 1.17 % | as of Dec 31, 2025 ↗ | |
| LAGO ERIE, SICAV, S.A. GESALCALA, S.A., S.G.I.I.C. | 81.3K € | 0.22 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Counterpoint Quantitative Equity ETF NORTHERN LIGHTS FUND TRUST III | 2.07 % | as of Jun 30, 2026 ↗ |
| iShares Genomics Immunology and Healthcare ETF iShares Trust | 1.52 % | as of Jul 31, 2026 ↗ |
| GESTION BOUTIQUE VIII, FI GESTION BOUTIQUE VIII / INVER VALUE GLOBAL FUND ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 1.17 % | as of Dec 31, 2025 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 0.73 % | as of Jul 31, 2026 ↗ |
| Driehaus Micro Cap Growth Fund Driehaus Mutual Funds | 0.32 % | as of Jun 30, 2026 ↗ |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 0.32 % | as of Dec 31, 2025 ↗ |
| LAGO ERIE, SICAV, S.A. GESALCALA, S.A., S.G.I.I.C. | 0.22 % | as of Dec 31, 2025 ↗ |
| State Street(R) SPDR(R) S&P(R) International Small Cap ETF SPDR INDEX SHARES FUNDS | 0.15 % | as of Jun 30, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 0.15 % | as of May 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 0.14 % | as of Jun 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 25 | +4 | 20,024,808 | +12.7 % |
| 2026Q2 | 21 | +1 | 17,772,652 | +0.9 % |
| 2026Q1 | 20 | -1 | 17,619,973 | +0.2 % |
| 2025Q4 | 21 | 0 | 17,576,923 | +0.5 % |
| 2025Q3 | 21 | 0 | 17,480,851 | +0.4 % |
| 2025Q2 | 21 | 0 | 17,414,555 | +57.7 % |
| 2025Q1 | 21 | -1 | 11,039,940 | +202.6 % |
| 2024Q4 | 22 | -6 | 3,648,642 | -65.8 % |
| 2024Q3 | 28 | -4 | 10,666,569 | -27.4 % |
| 2024Q2 | 32 | -2 | 14,698,689 | -0.8 % |
| 2024Q1 | 34 | -3 | 14,810,991 | -5.8 % |
| 2023Q4 | 37 | 15,716,947 |
Cite this page
Titelia. "Fund shareholders of ABCELLERA BIOLOGICS INC". https://titelia.com/en/stocks/abcellera-biologics-inc-CA00288U1066